Who should be treating rectal cancer in 2013?

No Thumbnail Available
Authors
Thompson, Chris
Williams, J Graham
Issue Date
2013-07-01
Type
Article
Peer-Reviewed Publication
Keywords
Combined modality therapy
Evidence-based medicine
Outcome assessment
Outcome process
Rectal cancer
Rectal neoplasms
Peer-reviewed article
Review
Specialization
Journal
British Journal of Hospital Medicine
Volume
74
Issue
7
Research Projects
Organizational Units
Journal Issue
Alternative Title
Abstract
Management of rectal cancer has advanced significantly over the last 30 years. As the complexity of treatment increases the question of superspecialization has arisen as a means of concentrating expertise and improving outcome. This article argues that this may have merit, but only for very early and very advanced tumours.
Management of rectal cancer has advanced significantly over the last 30 years. As the complexity of treatment increases the question of superspecialization has arisen as a means of concentrating expertise and improving outcome. This article argues that this may have merit, but only for very early and very advanced tumours.
Description
Published online 27 September 2013. Published in print 1 July 2013
Citation
Thompson C, Williams JG. Who should be treating rectal cancer in 2013? Br J Hosp Med (Lond). 2013 Jul;74(7):372-6. doi: 10.12968/hmed.2013.74.7.372. PMID: 24159636.
EISSN